These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10150465)

  • 1. Medication monitoring in the elderly.
    Fowler JB
    Clin Lab Sci; 1995; 8(1):34-8. PubMed ID: 10150465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of aging on serum phenytoin concentrations: a pharmacokinetic analysis based on therapeutic drug monitoring data.
    Battino D; Croci D; Mamoli D; Messina S; Perucca E
    Epilepsy Res; 2004; 59(2-3):155-65. PubMed ID: 15246117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and pharmacodynamic monitoring of the elderly in critical care.
    Planchock NY; Slay LE
    Crit Care Nurs Clin North Am; 1996 Mar; 8(1):79-89. PubMed ID: 8695038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing antiepileptic drug therapy in the elderly.
    Garnett WR
    Ann Pharmacother; 2005 Nov; 39(11):1852-60. PubMed ID: 16189285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digoxin prescribing for heart failure in elderly residents of long-term care facilities.
    Misiaszek B; Heckman GA; Merali F; Turpie ID; Patterson CJ; Flett N; McKelvie RS
    Can J Cardiol; 2005 Mar; 21(3):281-6. PubMed ID: 15776118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring in high level care.
    Shakib S; George A
    Aust Fam Physician; 2003 Nov; 32(11):905-8. PubMed ID: 14650785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for prevention of medication-related falls in the elderly.
    Keller RB; Slattum PW
    Consult Pharm; 2003 Mar; 18(3):248-58. PubMed ID: 16563058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethics related to drug therapy in the elderly.
    Beglinger C
    Dig Dis; 2008; 26(1):28-31. PubMed ID: 18600011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiepileptic drugs--best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies.
    Patsalos PN; Berry DJ; Bourgeois BF; Cloyd JC; Glauser TA; Johannessen SI; Leppik IE; Tomson T; Perucca E
    Epilepsia; 2008 Jul; 49(7):1239-76. PubMed ID: 18397299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aging: laboratory testing and theories.
    Gorman LS
    Clin Lab Sci; 1995; 8(1):24-30. PubMed ID: 10172352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of anthracycline-induced cardiotoxicity.
    Jannazzo A; Hoffman J; Lutz M
    Ann Pharmacother; 2008 Jan; 42(1):99-104. PubMed ID: 18094345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polypharmacy in the elderly: maximizing benefit, minimizing harm.
    Ballentine NH
    Crit Care Nurs Q; 2008; 31(1):40-5. PubMed ID: 18316935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic drug monitoring in general practice--indications and interpretation].
    Bode-Böger SM; Böger RH; Frölich JC
    Z Arztl Fortbild (Jena); 1993 Mar; 87(3):201-10. PubMed ID: 8470405
    [No Abstract]   [Full Text] [Related]  

  • 15. Cephalosporin-induced neurotoxicity: clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring.
    Grill MF; Maganti R
    Ann Pharmacother; 2008 Dec; 42(12):1843-50. PubMed ID: 19033476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical sedation scores as indicators of sedative and analgesic drug exposure in intensive care unit patients.
    Masica AL; Girard TD; Wilkinson GR; Thomason JW; Truman Pun B; Nair UB; Light RW; Canonico AE; Dunn J; Pandharipande P; Shintani AK; Ely EW
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):218-31. PubMed ID: 17996661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian and threshold probabilities in therapeutic drug monitoring: when can serum drug concentrations alter clinical decisions?
    Schumacher GE; Barr JT
    Am J Hosp Pharm; 1994 Feb; 51(3):321-7. PubMed ID: 8160684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Individualized drug therapy in geriatrics].
    Vogt N
    Schweiz Med Wochenschr; 1998 Feb; 128(6):195-8. PubMed ID: 9540140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of old age and enzyme inducing comedication on the pharmacokinetics of valproic acid at steady-state: A case-matched evaluation based on therapeutic drug monitoring data.
    Fattore C; Messina S; Battino D; Croci D; Mamoli D; Perucca E
    Epilepsy Res; 2006 Aug; 70(2-3):153-60. PubMed ID: 16730950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appropriateness of therapeutic drug monitoring for lithium.
    Ratanajamit C; Soorapan S; Doang-ngern T; Waenwaisart W; Suwanchavalit L; Suwansiri S; Jantasaro S; Yanate I
    J Med Assoc Thai; 2006 Nov; 89(11):1954-60. PubMed ID: 17205880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.